Spectral Medical EBIT

Spectral Medical (EDTXF) currently reports a EBIT of $-33M as of June 2026. That compares with $-17M in the prior-year period — down 90.5% year over year. That is below the sector sector average of $2.5T. Use the charts on this page to explore Spectral Medical's EBIT history and peer comparisons.

Spectral Medical's EBIT decreased from $-17M to $-33M — a 90.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Spectral Medical's EBIT of $-33M is lower than the its sector sector average of $2.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Spectral Medical reported $-33M in EBIT as of June 2026. That compares with $-17M in the prior-year period — down 90.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-33M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.5T. From there, open related valuation or income-statement pages for Spectral Medical, and consider following EDTXF for alerts when major investors trade the stock.